- ¥75bn
- ¥58bn
- ¥67bn
- 77
- 69
- 80
- 91
Annual balance sheet for Espec, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17,300 | 16,156 | 14,300 | 16,796 | 12,768 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15,878 | 16,172 | 19,600 | 21,775 | 23,793 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 40,182 | 43,076 | 48,000 | 54,674 | 50,589 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12,368 | 12,388 | 12,501 | 14,126 | 15,925 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 58,607 | 61,922 | 67,176 | 78,235 | 75,847 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10,769 | 13,537 | 17,277 | 22,447 | 15,421 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 13,623 | 16,543 | 20,222 | 25,520 | 19,154 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 44,984 | 45,379 | 46,954 | 52,715 | 56,693 |
| Total Liabilities & Shareholders' Equity | 58,607 | 61,922 | 67,176 | 78,235 | 75,847 |
| Total Common Shares Outstanding |